Yan Leyfman, Executive Committee Member at Music Beats Cancer, shared on LinkedIn:
“Excited to be invited as a Featured Speaker at the LeukO Global Virtual Congress 2026, bringing together leaders from around the world on September 3-4.
I’ll be speaking on Patient to Trial: AI-Enabled Matching in CAR T-Cell Therapy and sharing our work at the intersection of AI, clinical trials, and cellular therapy.
As innovation accelerates, the challenge is no longer only developing better therapies – it’s ensuring we can connect the right patient to the right trial at the right time.
Looking forward to contributing to this global conversation and helping shape what comes next for AI-enabled cancer care.
September 3-4 | Virtual
Register for LeukO 2026: LeukO 2026: Global Virtual Congress on Leukemias.”
Other articles about LeukO 2026 on OncoDaily.